Supplementary Table S3 from Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
Published in 2024 by
Sara M. Tolaney,
Shom Goel 
,
Jorge Nadal,
Hannelore Denys ,
Manuel R. Borrego,
Lacey M. Litchfield,
Jiangang Liu,
Adams K. Appiah,
Yanyun Chen,
Fabrice André
,
Jorge Nadal,
Hannelore Denys ,
Manuel R. Borrego,
Lacey M. Litchfield,
Jiangang Liu,
Adams K. Appiah,
Yanyun Chen,
Fabrice André
